Humana (NYSE:HUM) Cut to “Hold” at TD Cowen

by · The Cerbat Gem

TD Cowen lowered shares of Humana (NYSE:HUM – Free Report) from a buy rating to a hold rating in a report issued on Monday, MarketBeat Ratings reports. TD Cowen currently has $261.00 target price on the insurance provider’s stock, down from their previous target price of $402.00.

A number of other research analysts have also weighed in on the company. Jefferies Financial Group lowered Humana from a buy rating to a hold rating and decreased their price objective for the company from $519.00 to $253.00 in a report on Monday. Cantor Fitzgerald reissued a neutral rating and issued a $395.00 price target on shares of Humana in a research note on Tuesday, October 1st. Leerink Partners cut shares of Humana from an outperform rating to a market perform rating and dropped their price objective for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Bank of America lowered shares of Humana from a neutral rating to an underperform rating and decreased their target price for the stock from $376.00 to $247.00 in a research note on Wednesday, October 2nd. Finally, Oppenheimer dropped their price target on Humana from $400.00 to $280.00 and set an outperform rating for the company in a research report on Thursday, October 3rd. One equities research analyst has rated the stock with a sell rating, eighteen have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $324.86.

Check Out Our Latest Research Report on Humana

Humana Stock Performance

HUM opened at $245.43 on Monday. The firm’s fifty day simple moving average is $331.35 and its two-hundred day simple moving average is $341.88. Humana has a 52-week low of $213.31 and a 52-week high of $530.54. The company has a market cap of $29.57 billion, a price-to-earnings ratio of 15.28, a PEG ratio of 2.44 and a beta of 0.50. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the company posted $8.94 EPS. Humana’s quarterly revenue was up 10.4% compared to the same quarter last year. Equities analysts anticipate that Humana will post 16.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.44%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Mendota Financial Group LLC increased its position in shares of Humana by 9.2% in the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 27 shares during the last quarter. Aurora Investment Counsel raised its stake in Humana by 1.3% in the fourth quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after buying an additional 29 shares in the last quarter. Capital Advisors Ltd. LLC raised its stake in Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after buying an additional 31 shares in the last quarter. EP Wealth Advisors LLC boosted its position in shares of Humana by 1.6% during the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock worth $1,050,000 after acquiring an additional 37 shares in the last quarter. Finally, CarsonAllaria Wealth Management Ltd. increased its holdings in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also